Author: Vyas Tungaturti

Vyas Tungaturti is a seasoned M&A operator and advisor specializing in large-scale mergers, acquisitions, and private equity due diligence. His experience spans integration and divestiture office leadership, complex cross-border transactions, and the application of AI and machine learning to deal execution. Founder of CorpDev.Org and builder of Kai, an AI due-diligence platform for deal teams, Vyas writes on deal intelligence, value creation, and how AI is reshaping M&A and PE workflows.

CD&R raises $10bn in initial closing of latest PE fund [Daily News]

CD&R raises $10bn in initial closing of latest PE fund Submitted 26/09/2022 - 10:38am Clayton, Dubilier & Rice has held the initial closing of its latest private equity fund with around $10...

Private’s equity’s biggest problem [Mergers & Acquisitions]

The industry is not a pyramid scheme but it might be operating in an alternate reality Source Author: unknown

Cano, One Medical spark buyout interest amid shift to value-based care [buyout/ takeover]

JJ Gouin/iStock via Getty Images From Cano Health (CANO) to One Medical (ONEM), the companies exposed to value-based care (VBC) are on a roll amid rising buyout interest as the industry heavyweights...

Private equity parties on French Riviera and targets retail investors [buyout/ takeover]

Buyout industry faces a reckoning but some executives still predict a ‘golden age’ Source Author: unknown

Aveva investors plan to reject £9.5bn Schneider takeover [Private Equity Insights]

Mawer and M&G say £9.5bn bid from French group undervalues UK software developer A top-10 investor in Aveva plans to reject Schneider Electric’s £9.5bn takeover of the software developer on...

Citi to slash lending to buyout funds as new capital rules bite [buyout/ takeover]

Bank preparing to reduce size of ‘subscription line’ book from $65bn to $20bn Source Author: unknown

Citi to slash lending to buyout funds as new capital rules bite [buyout/ takeover]

Bank preparing to reduce size of ‘subscription line’ book from $65bn to $20bn Source Author: unknown

6 Key Reasons Why M&A Deals Are Falling Apart [Law360: Mergers & Acquisitions]

By Al Barbarino (September 23, 2022, 10:01 AM EDT) -- In the world of mergers and acquisitions, the word "definitive" isn't always, well, definitive.... Stay ahead of the curve In the legal...

Bristol-Myers Must Face Celgene Deal Suit In NJ State Court [Law360: Mergers & Acquisitions]

By Bill Wichert (September 23, 2022, 4:22 PM EDT) -- A New Jersey federal judge has sent back to state court class claims alleging Bristol-Myers Squibb Co. misled investors with respect to its $74...

Musk Loses Bid For Privilege Waiver Amid Twitter Doc Fight [Law360: Mergers & Acquisitions]

By Hailey Konnath (September 23, 2022, 10:04 PM EDT) -- The Delaware Chancery Court on Friday refused Tesla CEO Elon Musk's request for a "blanket" waiver of the attorney-client privilege...